Happy 2023 from the D.T.R.G Team
We at the D.T.R.G would like to thank our amazing staff and collaborators on what truly was an excellent 2022.
Just a few of our many accomplishments for the year include:
The commencement of the Renal Hybrid Closed Loop Study – A world first trial aiming to alleviate the mental, emotional and physical burdens attached to patients suffering from both diabetes and advanced renal disease
The appointment of Professor David O’Neal as Deputy Director of ACADI– Through this role at The Australian Centre for Accelerating Diabetes Innovations, David is looking forward to further helping patients with diabetes and assisting with new technologies to support them.
Recognition for our world first research at a National level through the ABC and St Vincent’s Health reports amongst other publications.
Our team was part of numerous conferences and publications throughout 2022, with many projects continuing into the new year.
We have seen the growth and development of many other studies lead by our team members, such as the SLC Study and REGENT-1.
We at the D.T.R.G would like to thank all of our team for the amazing progress made throughout 2022 and look forward to making even more developments in the coming year.
Onward and upward to 2023!
We are looking forward to many developments in what is already shaping up to be an exciting year in the world of Diabetes Research.